Related Experiment Video
Updated: Jun 4, 2025
Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model
Published on: April 2, 2021
Update on Management of Retinopathy of Prematurity: A Review
Celine Chaaya1, Sandra Hoyek2, Nimesh A Patel2,3
1Faculty of Medicine, Saint Joseph University of Beirut, Beirut, Lebanon.
Insights
Retinopathy of prematurity (ROP) management advances include anti-VEGF injections and improved screening. This review covers current and potential ROP treatments and screening strategies for premature infants.
Area of Science:
- Neonatal care
- Ophthalmology
- Perinatal medicine
Background:
- Retinopathy of prematurity (ROP) is a significant concern in neonatal intensive care.
- Improved survival rates of premature infants increase ROP prevalence.
- Advances in neonatal practices necessitate updated ROP management strategies.
Purpose of the Study:
- To review current treatment and screening methods for ROP.
- To explore emerging therapeutic tools for ROP.
- To discuss advancements in ROP management and screening.
Main Methods:
- Literature review of ROP treatments.
- Analysis of current ROP screening practices.
- Exploration of novel ROP therapeutic targets.
Main Results:
- Intravitreal anti-VEGF injections are a key treatment alongside laser photocoagulation.
- Screening practices are evolving towards efficiency and tele-screening.
- Advancements aim to improve outcomes for premature infants with ROP.
Conclusions:
- Current ROP management integrates anti-VEGF therapy and enhanced screening.
- Tele-screening offers efficient ROP detection and management.
- Ongoing research explores new therapeutic avenues for ROP.
Abstract:
Retinopathy of prematurity (ROP) remains a significant health care concern in neonatal care as advances in neonatal intensive practices have improved the survival rates of premature infants. The management and screening of ROP have evolved significantly, with notable trends and advancements aimed at improving outcomes. The use of intravitreal antivascular endothelial growth factor injections has emerged as a prominent initial treatment for ROP in addition to laser photocoagulation. Screening practices have also seen enhancements, with a shift toward efficiency and tele-screening to optimize ROP management. This review aims to discuss available treatment and screening methods and explore new potential therapeutic tools for ROP.
